BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2002
View Archived Issues
Epicyte partners with aaiPharma to develop topical monoclonal antibody
Read More
MalariVax phase I commences at U.S. and U.K. sites
Read More
Discovery of back-up HNE inhibitors detailed by GSK
Read More
E-selectin vaccine prevents stroke in rat model
Read More
Roche designs neuroprotective agents with reduced side effect liability
Read More
Sustained beneficial effects reported for tadalafil in men with ED
Read More
Research findings support use of KRP-197 for overactive bladder
Read More
Micrologix acquires antiviral product and technology portfolio
Read More
Incenta presents new cruzipain inhibitors for use in Chagas' disease
Read More
AWD-12-281 compares favorably with other PDE4 inhibitors in terms of safety margin
Read More
Novel IL-8 antagonists and their use in psoriasis, arthritis, etc.
Read More
Merck and Isis researchers identify new HCV NS5B polymerase inhibitors
Read More
New alpha4beta1/alpha4beta7 integrin antagonists identified at Almirall Prodesfarma
Read More
Coagulation factor inhibitors covered by Merck patent
Read More
Lipoxin A4 produced in human bronchial epithelium, exerts antiinflammatory effects
Read More
Phase III Tarceva trial in NSCLC completes enrollment
Read More
Pharmexa reacquires AutoVac(TM) TNF-alpha pharmaccine
Read More
European approval for Fosrenol delayed
Read More
SuperGen's decitabine awarded orphan drug status for sickle cell anemia
Read More
Tularik advances T-487 into phase I trials
Read More
Xigris evaluated in severe sepsis patients at low risk of death
Read More
Provigil improves ADHD symptoms in children
Read More
Therion licenses rights to ICAM-1 from Boehringer Ingelheim
Read More
Debiopharm and Biolex form recombinant human therapeutic protein collaboration
Read More
Dyax schedules second phase II trial of DX-88 in hereditary angioedema
Read More